加速器制备医用68Ga的技术进展

Current Development in the Cyclotron Production of 68Ga for Medical Application

  • 摘要: 68Ga是一种正电子核素,其标记的放射性药物被广泛应用于临床正电子发射断层扫描(PET)显像,以实现肿瘤等疾病的诊断。目前,68Ga主要通过68Ge/68Ga发生器制备,该方法适用68Ga用量较小或没有加速器的场景;此外,国内外学者开展了经68Zn(p, n)68Ga核反应,采用加速器以固体靶或液体靶的方式直接制备68Ga 的研究,该方法适合68Ga用量较大或有加速器的场景,可作为68Ge/68Ga发生器方法的有效补充。本文总结加速器直接制备68Ga的现状,并详述制靶、分离和富集68Zn靶回收等关键技术进展,以期为国内68Ga制备及其标记药物的研究提供参考。

     

    Abstract: As a positron-emitting radionuclide, 68Ga labeled radiopharmaceuticals are widely used in positron emission tomography (PET) imaging to diagnose tumor-related diseases. Currently, 68Ga is primarily supplied by 68Ge/68Ga generator. However, this approach is best suited for situations requiring small quantities of 68Ga or lacking access to a cyclotron. Alternatively, researchers worldwide have explored the direct production of 68Ga using cyclotron, employing solid or liquid targets via the 68Zn(p,n)68Ga nuclear reaction. This cyclotron-based method is ideal for generating larger quantities of 68Ga where cyclotron facilities are available, thus serving as a vital supplement to the generator method. This work reviews the status of direct preparation 68Ga in accelerator. It details the key steps in targetry, target chemistry, and 68Zn recycling, aiming to support 68Ga related research.

     

/

返回文章
返回